The operating characteristics of prostate-specific antigen in a population with initial PSA of 3.0 ng/ml or lower
Journal of the American Medical Association
2005
294
1
66-70
An estimator for treatment comparisons among survivors in randomized trials
Biometrics
2005
61
305-310
And educational program to increase cervical and breast cancer screening in Hispanic women: A Southwest Oncology Group Study
Cancer Nursing
2005
28
1
47-53
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
BMC Immunology
2005
6
1
17
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial
Journal of Urology
2005
174
3
Sep
877--881